Kate Weiss
Impact in
-
- Renal cell carcinoma treatment
- Ferroptosis and cancer prognosis
-
- Immune Cell Function and Interaction
- IL-33, ST2, and ILC Pathways
Papers in
-
- Renal cell carcinoma treatment 6
-
- Renal and related cancers 4
- Co-authors
- A. Ari Hakimi (7 shared papers)Paul Russo (4 shared papers)Renzo G. DiNatale (4 shared papers)Fengshen Kuo (2 shared papers)Jonathan Coleman (5 shared papers)Ritesh R. Kotecha (4 shared papers)Emily R. Kansler (1 shared paper)Briana G. Nixon (1 shared paper)
- Journals
- Nature Immunology (1 paper)Clinical Cancer Research (1 paper)European Urology (1 paper)The Journal of Urology (1 paper)Cancer (1 paper)
- Partner nations
- United StatesAustraliaCanada
In The Last Decade
Kate Weiss
7 papers receiving 143 citations
Peers
Comparison fields: 5 of 31
- Pulmonary and Respiratory Medicine 73
- Immunology 45
- Cancer Research 31
- Oncology 40
- Surgery 42
Countries citing papers authored by Kate Weiss
This map shows the geographic impact of Kate Weiss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kate Weiss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kate Weiss more than expected).
Fields of papers citing papers by Kate Weiss
This network shows the impact of papers produced by Kate Weiss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kate Weiss. The network helps show where Kate Weiss may publish in the future.
Co-authors
The 25 scholars most cited alongside Kate Weiss, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 55 | |
| 2 | 2020 | 33 | |
| 3 | 2022 | 20 | |
| 4 | 2022 | 17 | |
| 5 | 2021 | 14 | |
| 6 | 2021 | 3 | |
| 7 | 2021 | 1 |
About Kate Weiss
Kate Weiss is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Surgery, Oncology and Epidemiology, having authored 7 papers that have together received 143 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (6 papers), Renal and related cancers (4 papers), Cancer Genomics and Diagnostics (1 paper), Bladder and Urothelial Cancer Treatments (1 paper), Tuberous Sclerosis Complex Research (1 paper), IL-33, ST2, and ILC Pathways (1 paper), Pancreatic and Hepatic Oncology Research (1 paper) and T-cell and Retrovirus Studies (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (73 citations), Immunology (45 citations), Cancer Research (31 citations), Oncology (40 citations) and Surgery (42 citations). Kate Weiss has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include A. Ari Hakimi, Paul Russo, Renzo G. DiNatale, Fengshen Kuo, Jonathan Coleman, Ritesh R. Kotecha, Emily R. Kansler, Briana G. Nixon, Stanley Weng and Guangwei Cui. Their work appears in journals such as Nature Immunology, Clinical Cancer Research, European Urology, The Journal of Urology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.